On Friday, Shares of Houghton Mifflin Harcourt Co (NASDAQ:HMHC), gained 0.61% to $26.38.
Scholastic Corporation, declared it had accomplished the formerly stated sale of its Educational Technology and Services business segment to Houghton Mifflin Harcourt Company, counting the equity in International Center for Leadership in Education and Tom Snyder Productions, Inc., for $575 million in cash, subject to adjustment. The sale was accomplished following a Stock and Asset Purchase Agreement reached on April 24, 2015, as formerly revealed in a Current Report on Form 8-K filed with the Securities and Exchange Commission. With the completion of the sale, Scholastic will remain focused on growing its core children’s book business, counting school book clubs, book fairs and trade, and the publishing and sale to schools of print and digital instructional materials, both in the US and around the world, with a major presence in Canada, Australia, UK, and Asia.
Houghton Mifflin Harcourt Company provides education solutions for educational institutions and consumers worldwide. It delivers content, technology, and services to about 50 million students.
Shares of TTM Technologies, Inc. (NASDAQ:TTMI), inclined 0.10% to $ 9.88, during its last trading session.
TTM Technologies, declared that a certificate of merger regarding TTM’s acquisition of Via systems Group, has been filed with the Secretary of State of the State of Delaware, providing for an effective time for the merger of Sunday, May 31, 2015 at 11:59 p.m. ET.
TTM Technologies, Inc., together with its auxiliaries, provides various printed circuit board products and backplane assemblies worldwide. The company offers high density interconnect, conventional, flexible, and rigid-flex PCBs, in addition to backplane assemblies and IC substrates.
At the end of Friday’s trade, Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD), gained 0.98% to $ 12.31.
Amicus Therapeutics, declared that the Committee for Medicinal Products for Human Use of the European Medicines Agency has granted Accelerated Assessment to the oral small molecule pharmacological chaperone migalastat HCl monotherapy for Fabry patients who have amenable genetic mutations.
Migalastat is the first investigational Fabry drug to be granted Accelerated Assessment. Amicus requested Accelerated Assessment in accordance with the EMA guidelines, which justify Accelerated Assessment for therapies that are predictable to be of major public health interest and therapeutic innovation, addressing the greater unmet needs for maintaining and improving the health of the Community.Over the past three years, positive opinions were granted after an Accelerated Assessment for a total of just 14 therapies.The most recent innovative treatment options to have been granted Accelerated Assessment comprise therapies for rare diseases such as Morquio A Syndrome, Lysosomal Acid Lipase Deficiency, and Cystic Fibrosis.
Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. Its product candidate is a small molecule that can be used as a monotherapy and in combination with enzyme replacement therapy for Fabry disease.
Finally, Brinker International, Inc. (NYSE:EAT), ended its last trade with -0.72% loss, and close at $ 55.18.
Brinker International, declared a quarterly dividend of $0.28 per share on the common stock of the company. The dividend will be payable June 25, 2015 to shareholders of record as of June 12, 2015.
Brinker International, Inc. is one of the world’s leading casual dining restaurant companies. Founded in 1975 and based in Dallas, Texas, as of March 25, 2015, Brinker owned, operated, or franchised 1,629 restaurants under the names Chili’s Grill & Bar and Maggiano’s Little Italy.
Brinker International, Inc. owns, develops, operates, and franchises casual dining restaurants under the Chili’s Grill & Bar and Maggiano’s Little Italy brands worldwide. As of September 24, 2014, it owned, operated, or franchised 1,622 restaurants. The company was founded in 1975 and is based in Dallas, Texas.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
